The US Food and Drug Administration (FDA)’s recently issued final rule establishing application, labeling, and postmarketing reporting requirements for a nonprescription drug product with an “additional condition for...more
1/17/2025
/ Final Rules ,
Food and Drug Administration (FDA) ,
Healthcare ,
New Regulations ,
Over The Counter Drugs (OTC) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Product Labels ,
Public Health ,
Regulatory Requirements ,
Reporting Requirements